Early testing for Huntington disease in children: pros and cons

Megan Toufexis1, Maria Gieron-Korthals

  • 1Department of Psychiatry and Behavioral Medicine, University of South Florida, College of Medicine, Tampa, Florida, USA. mtoufexi@health.usf.edu

Insights

Premature genetic testing for Huntington disease in children can lead to significant medical and psychological challenges. Testing should only occur when symptoms are evident and other conditions are ruled out, with family support.

Area of Science:

  • Neurology
  • Genetics
  • Pediatrics

Background:

  • Huntington disease (HD) is a progressive neurodegenerative disorder.
  • Juvenile Huntington disease (JHD) presents before age 20.
  • Genetic testing for HD is available but carries significant ethical considerations, especially in minors.

Observation:

  • This report details two cases of young children who underwent premature genetic testing for Huntington disease.
  • The cases highlight the complex medical and psychological ramifications for both the child and their family.
  • Premature testing in minors raises unique challenges compared to adult testing.

Findings:

  • Early, pre-symptomatic testing in children can lead to adverse psychological outcomes and social difficulties.
  • The benefits of early testing must be carefully weighed against the potential harms.
  • Diagnosing JHD requires careful exclusion of other neurological conditions that mimic its symptoms.

Implications:

  • Genetic testing for Huntington disease in children should be deferred until symptoms manifest and are progressive.
  • A multidisciplinary team approach is crucial for comprehensive genetic counseling and support.
  • Informed decision-making requires thorough education on the risks, benefits, and long-term consequences of testing for families.